Bone Health News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–4 of 4 articles
Earlier
Critical impact NewsMay 3, 2026
BioMarin VOXZOGO Shows Long-Term Benefits for Achondroplasia in New Clinical Data at PES 2026
2 min
Dr. Emily CarterHigh impact NewsApr 16, 2026
Mabwell's MAIWEIJIAN Denosumab Gets NMPA Acceptance for Expanded Cancer Bone Treatment
2 min
James Chen, PharmDHigh impact NewsApr 13, 2026
FDA Approves OsteoBuild: New Bone-Building Agent for Severe Osteoporosis
FDA · Osteoporosis · 5 min
Dr. Sarah MitchellHigh impact NewsApr 2, 2026
FDA Approves Elarek: New Option for Osteoporosis Prevention
FDA · Osteoporosis · 6 min
Dr. Sarah MitchellExplore intelligence